About XCyton Diagnostics
XCyton Diagnostics is a company based in Bengaluru (India) founded in 1993 by Latha Lakshman. XCyton Diagnostics has raised $5.49 million across 5 funding rounds from investors including Fidelity Investments, Fil Capital Advisors Trustee Company and Amvar Ventures. The company has 23 employees as of April 07, 2024. XCyton Diagnostics offers products and services including Syndrome Evaluation System and Molecular Diagnostic Services. XCyton Diagnostics operates in a competitive market with competitors including Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
- Headquarter Bengaluru, India
- Employees 23 as on 07 Apr, 2024
- Founders Latha Lakshman
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xcyton Diagnostics Private Limited
- Date of Incorporation 30 Sep, 1993
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$186.76 K (USD)-75.3as on Mar 31, 2023
-
Net Profit
-$587.18 K (USD)-815.91as on Mar 31, 2023
-
EBITDA
-$304.87 K (USD)-236.16as on Mar 31, 2023
-
Total Equity Funding
$5.49 M (USD)
in 5 rounds
-
Latest Funding Round
$167.05 K (USD), Unspecified
Mar 30, 2014
-
Investors
Fidelity Investments
& 5 more
-
Employee Count
23
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of XCyton Diagnostics
XCyton Diagnostics offers a comprehensive portfolio of products and services, including Syndrome Evaluation System and Molecular Diagnostic Services.
Patented technology for rapid multiplex amplification and syndrome identification.
Offers tests and facilities for critical care diagnostics applications.
Funding Insights of XCyton Diagnostics
XCyton Diagnostics has successfully raised a total of $5.49M across 5 strategic funding rounds. The most recent funding activity was a Unspecified round of $167.05 thousand completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in XCyton Diagnostics
XCyton Diagnostics has secured backing from 6 investors, including institutional and angel investors. Prominent investors backing the company include Fidelity Investments, Fil Capital Advisors Trustee Company and Amvar Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms
|
Locked | Locked | Locked | |
|
Trustee services in financial advising are managed in India.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for XCyton Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by XCyton Diagnostics
Investment portfolio details for XCyton Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - XCyton Diagnostics
Detailed financials for XCyton Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xcyton Diagnostics Comparisons
Peer comparison for XCyton Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of XCyton Diagnostics
XCyton Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
Detailed competitors of XCyton Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xcyton Diagnostics
Complete news archive for XCyton Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about XCyton Diagnostics
XCyton Diagnostics was founded in 1993 and raised its 1st funding round 14 years after it was founded.
XCyton Diagnostics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
XCyton Diagnostics is a funded company, having raised a total of $5.49M across 5 funding rounds to date.
As of Apr 07, 2024, the latest employee count at XCyton Diagnostics is 23.
Annual revenue of XCyton Diagnostics is $186.76K as on Mar 31, 2023.
XCyton Diagnostics was founded in 1993 in Bengaluru, India, within the healthcare sector. Molecular diagnostic products and services are offered, with a focus on medical diagnosis for critical care infections. Immunodiagnostic services, molecular diagnostics, and clinical tests are included in the portfolio. Operations are based in India, serving diagnostic needs in clinical settings.
XCyton Diagnostics's top competitors include Visby Medical, Inflammatix and Prenetics.
XCyton Diagnostics offers Syndrome Evaluation System and Molecular Diagnostic Services.
XCyton Diagnostics has 6 investors. Key investors include Fidelity Investments, Fil Capital Advisors Trustee Company, Amvar Ventures, Arun Kumar Sekhran, and Sudha Ranganathan.
The valuation of XCyton Diagnostics is $4.88M as of Mar 2014.